The country’s top research body may have provisionally recommended prescribing puberty suppressants to young trans and gender diverse Australians, but Queensland’s health minister says the state’s position on the drugs remains unchanged.
On Monday, federal health minister Mark Butler announced that the National Health and Medical Research Council had released interim advice conditionally recommending the consideration of gonadotropin-releasing hormone agonists for patients with gender congruence under the age of 18.
It came with several caveats, including that the young person has been diagnosed with gender incongruence, has commenced puberty (defined as Tanner stage 2 or later), and is assessed as suitable for treatment in collaboration with clinicians.
It also emphasised the importance of shared decision making between the patient, their parent or guardian, and the treating clinician.
Mr Butler urged both Queensland and the Northern Territory to reconsider existing bans on public hospital puberty blocker prescriptions in light of the recommendation.




